Barclays (BCS) recently won the dismissal of two U.S. securities fraud lawsuits related to the unauthorized issuance of $17.7 billion in securities. This legal victory is expected to positively impact investor sentiment and reduce legal uncertainties surrounding the stock.
The stock is currently trading at $15.75, with a neutral RSI of 53.41, indicating no overbought or oversold conditions. The MACD is slightly bullish, suggesting potential upward momentum.
The Fibonacci levels indicate resistance at $16.13 (R1) and support at $14.78 (S1). The stock is likely to face selling pressure near the resistance level.
Based on the technical indicators and news sentiment, the stock is expected to rise slightly toward the resistance level. The predicted price target for the next trading week is $16.20.
Sell near the resistance level of $16.13, as the stock may face selling pressure at this point.
The price of BCS is predicted to go up 0.76%, based on the high correlation periods with AACT. The similarity of these two price pattern on the periods is 95.26%.
BCS
AACT
Thanks to a reduction in risk-weighted assets, Barclays' capital ratio has improved over the years.
Barclays' has a strong place in the U.K. retail banking business with healthy shares of personal accounts and leadership position with Barclaycard.
Its improved capital ratio allows Barclays to distribute excess capital to shareholders including share repurchases.